Modulation of Adipocytokines Response and Weight Loss Secondary to a Hypocaloric Diet in Obese Patients by -55CT Polymorphism of UCP3 Gene

Abstract

Decreased expression or function of UCP3 (uncoupling protein 3) could reduce energy expenditure and increase the storage of energy as fat. Some studies have pointed to a role of UCP3 in the regulation of whole body energy homeostasis, diet induced obesity, and regulation of lipids as metabolic substrates. The C/C genotype of a polymorphism in the UCP3 promoter (-55C→T) is associated with an increased expression of UCP3 mRNA in muscle. The aim of our study was to investigate the influence of -55CT polymorphism of UCP3 gene on adipocytokines response and weight loss secondary to a hypocaloric diet in obese patients. A population of 107 obese (body mass index >30) nondiabetic outpatients was analyzed in a prospective way. Before and after three months of a hypocaloric diet, an indirect calorimetry, tetrapolar electrical bioimpedance, blood pressure, a serial assessment of nutritional intake with 3-day written food records, and biochemical analysis were performed. The lifestyle modification program consisted of a hypocaloric diet (1520 kcal, 52% of carbohydrates, 25% of lipids and 23% of proteins). The exercise program consisted of aerobic exercise for at least 3 times per week (60 minutes each). The mean age was 49.5±34.5 years and the mean BMI 34.5±4.8, with 27 males (25.3%) and 80 females (74.7%). Ninety patients (25 males/65 females) (83.6%) had the genotype 55CC (wild group) and 17 patients (2 male/15 females) (16.4%) 55CT (mutant group). The percentage of responders (weight loss) was similar in both groups (wild group: 84.7% vs. mutant group: 81.8%). BMI, weight, fat mass, systolic blood pressure, LDL cholesterol, waist circumference, and waist-to-hip ratio decreased in the wild group and RMR and VO₂ were increased. In the mutant group, BMI and weight decreased. Leptin and IL-6 levels have a significant decrease in the wild group (9.6%: p<0.05) and (30.5%: p<0.05), respectively. Patients with -55CC genotype have a significant decrease in leptin, interleukin 6, BMI, weight, fat mass, systolic blood pressure, LDL cholesterol, waist circumference, waist-to-hip ratio weight, fat mass, and systolic blood pressure.

55CT polymorphism of UCP3 gene - diet - obesity

References

• 1 Aranceta J, Perez Rodrigo C, Serra Majem L. Prevalencia de la obesidad en España: estudio SEEDO 97.  Med Clin (Barc). 1998;  111 441-445
• 2 Tuomilehto J, Lindstrom J, Eriksson JG. Finnish Diabetes Prevention Study Group: prevention of type 2 diabetes mellitus changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  344 1343-1350
• 3 Matsuzawa Y. Adipocytokines: Emerging therapeutic targets.  Current Atherosclerosis Reports. 2005;  7 58-62
• 4 Vidal Puig A, Solanes G, Grujic D, Flier J, Lowell BB. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue.  Biochem Biophys Res Commun. 1997;  235 79-82
• 5 Saltzman E, Roberts SB. The role of energy expenditure in energy regulation: findings from a decade research.  Nutr Rev. 1995;  53 209-220
• 6 Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of uncoupling protein 2 gene and resisting metabolic rate in humans.  Hum Mol Gent. 1997;  6 1887-1889
• 7 Clapham J, Arch J, Chapman H. Mice overexpressing human uncoupling protein 3 in skeletal muscle are hyperphagic lean.  Nature. 2000;  406 415-418
• 8 Samec S, Seydoux J, Dullo A. Role of UCP homologues in skeletal muscle and free fatty acids in obesity.  Lancet. 1998;  351 1933-1934
• 9 Schrauwen P, Xia Xia J, Walder K, Snitker S, Ravussin E. A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle. UCP3 m RNA expression and obesity in male non-diabetic Pima Indians.  Int J Obes. 1999;  23 1242-1245
• 10 Otabe S, Clement K, Dina C. A genetic variation in the 5′ flanking region of the UCP3 is associated with body mass index in humans in interaction with physical activity.  Diabetologia. 2000;  43 245-249
• 11 Meirhaeghe A, Amoyel P, Helbecque N. An uncoupling protein 3 gene polymorphism associated with a lower risk of developing type 2 diabetes and with atherogenic lipid profile in a French cohort.  Diabetologia. 2000;  43 1424-1428
• 12 Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-414
• 13 Feurer ID, Mullen JL. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry.  Nutr Clin Pract. 1986;  1 43-49
• 14 Pichard C, Slosman D, Hirschel B, Kyle U. Bioimpedance analysis in AIDS patients: an improved method for nutritional follow up.  Clin Res. 1993;  41 53
• 15 Mataix J, Mañas M. Tablas de composición de alimentos españoles. Granada: University of Granada 1998
• 16 Hesselink MKC, Mensink M, Schrauwen P. Human uncoupling protein-3 and obesity.  Obes Res. 2003;  11 1429-1440
• 17 Millet L, Vidal H, Andreelli F. Increased uncoupling protein 2 and 3 mRNA expression during fasting in obese and lean humans.  J Clin Invest. 1997;  100 2665-2670
• 18 Cortright RN, Zheng D, Jones JP. Regulation of skeletal muscle UCP2 and UCP3 gene expression by exercise and denervation.  Am J Physiol. 1999;  276 217-221
• 19 Elbein SC, Lepperrt M, Hasstedt S. Uncoupling protein 2 region on chromosome 11q13 is not linked to markers of obesity in familial type 2 diabetes.  Diabetes. 1997;  46 2105-2107
• 20 Dalgaard LT, Sorensen TIA, Drivshom T, Borch Johnsen K, Andersen T, Hansen T. A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population.  J Clin Endoc Metab. 2001;  86 1398-1402
• 21 Alonso A, Marti A, Corbalan MS, Martinez Gonzalez MA, Forga L, Martinez JA. Association of UCP3 gene -55CT polymorphism and obesity in a Spanish population.  Ann Nutr Metab. 2005;  49 183-188
• 22 Liu YJ, Liu PY, Long J, Lu Y, Elze L, Recker RR, Deng HW. Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families.  Physiol Genomics. 2005;  22 197-203
• 23 Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersle AT. Evidence that single nucleotide polymorphism in the uncoupling protein 3 gene influences fat distribution in women of European and Asian origin.  Diabetologia. 2000;  43 1558-1564
• 24 Commins SP, Watson PM, Framton IC, Gettys TW. Leptin selectively reduces white adipose tissue in mice a UCO1 dependent mechanism in BAT.  J Physiol Endocrinol Metab. 2005;  280 372-377
• 25 Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue.  Int J Obes Relat Metab Disord. 2003;  27 875-888
• 26 Xenachis C, Samojlik E, Raghuwanshi MP, Kirschner MA. Leptin, insulin and TNF-alpha in weight loss.  J Endocrinol Invest. 2001;  24 865-870
• 27 Bastard JP, Jardel C, Bruckert E. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.  J Clin Endocrinol Metab. 2000;  85 3338-3342
• 28 Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mulloly C, Jarema C, Porter S, Ovalle K. Efect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.  Obes Res. 2003;  11 1048-1052
• 29 Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinolgy of adipose tissue-An update.  Horm Metab Res. 2007;  39 314-321
• 30 Garcia AL, Steiniger J, Reich SC, Weickert MO, Harsch I, Machowetz A. et al . Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance.  Horm Metab Res. 2006;  38 761-766
• 31 Kamari Y, Grossman E, Oron-herman M, Peleg E, Shabtay Z, Shamiss A, Sharabi Y. Metabolic stress with a high carbohydrate diet increases adiponectin levels.  Horm Metab Res. 2007;  39 384-388

Correspondence